▲ Peaking
Business
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex Pharmaceuticals is acquiring commercial endocrinology biotech Crinetics Pharmaceuticals in a $10 billion deal.
1 news trends Newsylist has tracked involving Crinetics Pharmaceuticals — newest first.
Vertex Pharmaceuticals is acquiring commercial endocrinology biotech Crinetics Pharmaceuticals in a $10 billion deal.